Inmmune Pharmaceuticals Inc, has requested a delisting of the company’s shares from NASDAQ OMX Stockholm AB (the “Exchange”). The company has instead applied for a listing of its shares on First North Premier.
The Exchange has approved the delisting application and decided to delist the shares of Immune Pharmaceuticals Inc.
| Short name: | IMPN |
| ISIN code: | US45254C1018 |
| Orderbook ID: | 32838 |
The last day of trading will be on November 29, 2013. As from December 2, the shares will be traded on First North Premier Stockholm.
For further information regarding this exchange notice please call Patrik Hellgren or Eva Norling, telephone + 46 8 405 60 00.